BOA™ Biomedical’s GARNET™ therapeutic product begins First in Human clinical trial
BOA Biomedical’s GARNET™ therapeutic product begins FIH clinical trial
BOA Biomedical’s GARNET™ therapeutic product begins FIH clinical trial
The study, expected to begin later this year, will take place at Walter Reed National Military Medical Center and at nonmilitary hospitals.
Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.
A Cambridge biomedical is developing a rapid coronavirus test that it hopes to have ready in a few months.